<ul>
	<li><strong>Pediatric Use</strong>: The safety and effectiveness of Cabozantinib in pediatric patients have not been established.</li>
	<li><strong>Geriatric Use</strong>: No overall differences in safety or effectiveness were observed between these patients and younger patients.</li>
	<li><strong>Renal Impairment</strong>: No dosage adjustment is recommended in patients with mild or moderate renal impairment.</li>
</ul>